MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Effects of High-frequency Repetitive Transcranial Magnetic Stimulation (HF-rTMS) Combined with Task Specific Training in Individuals with Parkinson’s Disease

    J. Thanakamchokchai, J. Tretriluxana, B. Fisher, N. Pakaprot, A. PisarnPong (Nakhon Pathom, Thailand)

    Objective: To examine the effects of HF-rTMS with reach-to-grasp (RTG) training focusing on the movement amplitude Background: Previous studies applied the HF-rTMS over primary motor…
  • 2018 International Congress

    Peripheral nerve grafts implanted into the substantia nigra in patients with Parkinson’s disease during deep brain stimulation surgery: 2-year follow-up study of gait parameters

    Z. Guduru, G. Gera, G. Quintero, C. Van Horne, G. Gerhardt (Lexington, KY, USA)

    Objective: Measuring gait parameters in patients with Parkinson's disease (PD) who underwent autologous peripheral nerve grafts implantation (surgical deployment of the Schwann cells obtained from…
  • 2018 International Congress

    A Computer-Aided Prescription Model for Parkinson’s Disease could predict the suitable drugs for Parkinson’s disease (PD) patients

    Y. Pan, L. Zhang (Nanjing, China)

    Objective: Using machine learning techniques to automatically recommend suitable drugs for Parkinson’s Disease (PD) patients, thereby providing computer-aided prescriptions. Background: PD is the second most…
  • 2018 International Congress

    Effects of rTMS on three cortical areas in Parkinson’s Disease

    V. Goyal, P. Bhat, C. Goyal, A. Srivastava, S. Kumaran, M. Behari, S. Dwivedi (Delhi, India)

    Objective: To evaluate the role of rTMS over primary motor area, premotor area, supplementary motor area in Parkinsons Disease. Background: Parkinson’s disease (PD) presents with…
  • 2018 International Congress

    Is there a relationship between depression/anxiety and physical inactivity in Parkinson Disease?

    B. Aktar, B. Balci, B. Donmez Colakoglu (Izmir, Turkey)

    Objective: To investigate the relationships between depression/anxiety and activity limitations in Parkinson disease (PD). Background: Depression, anxiety are common non-motor symptoms in PD. Depression which…
  • 2018 International Congress

    Update on The Personalized Parkinson Project: Partnering with Patients to Understand Disease Progression Through a Multi-Dimensional Approach

    B. Bloem, R. Kapur, T. v/d Zande, M. Faber, W. Marks, Jr (Nijmegen, Netherlands)

    Objective: Enrollment for The Personalized Parkinson Project (PPP) is underway. Co-design and mutual partnership between patients and researchers is a key characteristic of the project…
  • 2018 International Congress

    Effects of Rock Steady Boxing on Activities of Daily Living and Motor Symptoms of Parkinson’s Disease

    D. Larson, D. Bega, E. Johnson, L. Slowey (Chicago, IL, USA)

    Objective: To determine the impact of the Rock Steady Boxing (RSB) program on Parkinson’s disease (PD). To assess the feasibility of data collection for activities…
  • 2018 International Congress

    Liquid sinemet in the management of complex motor fluctuations in advanced Parkinson’s Disease

    C. Sung, M. Danoudis, R. Iansek (Melbourne, Australia)

    Objective: To investigate the effectiveness of Levodopa carbidopa ascorbic acid solution (LCAS) in reducing the severity of bradykinesia and dyskinesia in advanced Parkinson’s disease (PD).…
  • 2018 International Congress

    A novel mGlu4 PAM alleviates motor symptoms in primate models of PD and of LID

    D. Charvin, T. Di Paolo, E. Bezard, L. Gregoire, A. Takano, G. Duvey, E. Pioli, C. Halldin, R. Medori, F. Conquet (Plan-les-Ouates, Switzerland)

    Objective: Objective was to assess the therapeutic potential of our novel mGlu4 positive allosteric modulator (PAM), foliglurax, as an anti-parkinsonian treatment in gold-standard primate models.…
  • 2018 International Congress

    Clinical characteristics of turkish patients with Parkinson’s disease: A retrospective analysis of 428 patients

    B. Gonenli Kocer, E. Ozturk, S. Comoglu (Ankara, Turkey)

    Objective: To evaluate the demographic, motor and non-motor clinical characteristics of Turkish Parkinson’s disease (PD) patients in our Movement Disorders Outpatient Clinic. Background: Although PD…
  • « Previous Page
  • 1
  • …
  • 1222
  • 1223
  • 1224
  • 1225
  • 1226
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley